/
Stock
/
/
APIChangelogInfo

INTRA-CELLULAR THERAPIES

Trade ITCI
ITCI Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-04-02
2025-04-02
DURGAM SURESH
EVP, Chief Medical Officer
D - Sale to Issuer
Stock Option (right to buy)
-124K
4
$13.67B
2025-04-02
2025-04-02
SALAS EDUARDO RENE
D - Sale to Issuer
Stock Option (right to buy)
-48,088
4
$13.67B
2025-04-02
2025-04-02
SALAS EDUARDO RENE
D - Sale to Issuer
Common Stock
-1,567
$132.00
-207K
1
$13.67B
2025-04-02
2025-04-02
VAN NOSTRAND ROBERT
D - Sale to Issuer
Restricted Stock Units
-2,951
1
$13.67B
2025-04-02
2025-04-02
VAN NOSTRAND ROBERT
D - Sale to Issuer
Stock Option (right to buy)
-128K
8
$13.67B
2025-04-02
2025-04-02
VAN NOSTRAND ROBERT
D - Sale to Issuer
Common Stock
-11,340
$132.00
-1.50M
1
$13.67B
2025-04-02
2025-04-02
HALSTEAD MICHAEL
President
A - Grant
Performance Stock Units
25,374
$0.00
2
$13.67B
2025-04-02
2025-04-02
RIGGS RORY
D - Sale to Issuer
Common Stock
-132K
$132.00
-17M
1
$13.67B
2025-04-02
2025-04-02
DURGAM SURESH
EVP, Chief Medical Officer
A - Grant
Performance Stock Units
21,876
$0.00
2
$13.67B
2025-04-02
2025-04-02
MATES SHARON
Chairman and CEO
D - Sale to Issuer
Restricted Stock Units
-232K
3
$13.67B
2025-04-02
2025-04-02
DURGAM SURESH
EVP, Chief Medical Officer
A - Grant
Performance Stock Units
21,876
$0.00
2
$13.67B
2025-04-02
2025-04-02
HALSTEAD MICHAEL
President
A - Grant
Performance Stock Units
25,374
$0.00
2
$13.67B
2025-04-02
2025-04-02
MATES SHARON
Chairman and CEO
A - Grant
Performance Stock Units
75,682
$0.00
2
$13.67B
2025-04-02
2025-04-02
NEUMANN MARK
EVP, Chief Commercial Officer
A - Grant
Performance Stock Units
21,876
$0.00
2
$13.67B
2025-04-02
2025-04-02
DURGAM SURESH
EVP, Chief Medical Officer
D - Sale to Issuer
Performance Stock Units
-21,876
2
$13.67B
2025-04-02
2025-04-02
DURGAM SURESH
EVP, Chief Medical Officer
D - Sale to Issuer
Restricted Stock Units
-55,239
3
$13.67B
2025-04-02
2025-04-02
MATES SHARON
Chairman and CEO
A - Grant
Performance Stock Units
75,682
$0.00
2
$13.67B
2025-04-02
2025-04-02
DURGAM SURESH
EVP, Chief Medical Officer
D - Sale to Issuer
Common Stock
-42,913
$132.00
-5.66M
1
$13.67B
2025-04-02
2025-04-02
HALSTEAD MICHAEL
President
D - Sale to Issuer
Performance Stock Units
-25,374
2
$13.67B
2025-04-02
2025-04-02
HALSTEAD MICHAEL
President
D - Sale to Issuer
Restricted Stock Units
-83,065
3
$13.67B
2025-04-02
2025-04-02
HALSTEAD MICHAEL
President
D - Sale to Issuer
Stock Option (right to buy)
-58,388
2
$13.67B
2025-04-02
2025-04-02
HALSTEAD MICHAEL
President
D - Sale to Issuer
Common Stock
-21,307
$132.00
-2.81M
1
$13.67B
2025-04-02
2025-04-02
MARCUS JOEL
D - Sale to Issuer
Restricted Stock Units
-2,951
1
$13.67B
2025-04-02
2025-04-02
MARCUS JOEL
D - Sale to Issuer
Stock Option (right to buy)
-4,322
1
$13.67B
2025-04-02
2025-04-02
MARCUS JOEL
D - Sale to Issuer
Common Stock
-58,238
$132.00
-7.69M
2
$13.67B
2025-04-02
2025-04-02
MATES SHARON
Chairman and CEO
D - Sale to Issuer
Performance Stock Units
-75,682
2
$13.67B
2025-04-02
2025-04-02
NEUMANN MARK
EVP, Chief Commercial Officer
A - Grant
Performance Stock Units
21,876
$0.00
2
$13.67B
2025-04-02
2025-04-02
DURGAM SURESH
EVP, Chief Medical Officer
D - Sale to Issuer
Performance Stock Units
-21,876
2
$13.67B
2025-04-02
2025-04-02
DURGAM SURESH
EVP, Chief Medical Officer
D - Sale to Issuer
Restricted Stock Units
-55,239
3
$13.67B
2025-04-02
2025-04-02
DURGAM SURESH
EVP, Chief Medical Officer
D - Sale to Issuer
Stock Option (right to buy)
-124K
4
$13.67B
2025-04-02
2025-04-02
SALAS EDUARDO RENE
D - Sale to Issuer
Common Stock
-1,567
$132.00
-207K
1
$13.67B
2025-04-02
2025-04-02
DURGAM SURESH
EVP, Chief Medical Officer
D - Sale to Issuer
Common Stock
-42,913
$132.00
-5.66M
1
$13.67B
2025-04-02
2025-04-02
HALSTEAD MICHAEL
President
D - Sale to Issuer
Performance Stock Units
-25,374
2
$13.67B
2025-04-02
2025-04-02
HALSTEAD MICHAEL
President
D - Sale to Issuer
Restricted Stock Units
-83,065
3
$13.67B
2025-04-02
2025-04-02
HALSTEAD MICHAEL
President
D - Sale to Issuer
Stock Option (right to buy)
-58,388
2
$13.67B
2025-04-02
2025-04-02
HALSTEAD MICHAEL
President
D - Sale to Issuer
Common Stock
-21,307
$132.00
-2.81M
1
$13.67B
2025-04-02
2025-04-02
MARCUS JOEL
D - Sale to Issuer
Restricted Stock Units
-2,951
1
$13.67B
2025-04-02
2025-04-02
MARCUS JOEL
D - Sale to Issuer
Stock Option (right to buy)
-4,322
1
$13.67B
2025-04-02
2025-04-02
MARCUS JOEL
D - Sale to Issuer
Common Stock
-58,238
$132.00
-7.69M
2
$13.67B
2025-04-02
2025-04-02
MATES SHARON
Chairman and CEO
D - Sale to Issuer
Performance Stock Units
-75,682
2
$13.67B
2025-04-02
2025-04-02
MATES SHARON
Chairman and CEO
D - Sale to Issuer
Restricted Stock Units
-232K
3
$13.67B
2025-04-02
2025-04-02
MATES SHARON
Chairman and CEO
D - Sale to Issuer
Stock Option (right to buy)
-530K
6
$13.67B
2025-04-02
2025-04-02
MATES SHARON
Chairman and CEO
D - Sale to Issuer
Common Stock
-1.14M
$132.00
-150M
2
$13.67B
2025-04-02
2025-04-02
NARULA SANJEEV
Executive Vice President & CFO
D - Sale to Issuer
Restricted Stock Units
-57,773
2
$13.67B
2025-04-02
2025-04-02
NARULA SANJEEV
Executive Vice President & CFO
D - Sale to Issuer
Stock Option (right to buy)
-17,251
1
$13.67B
2025-04-02
2025-04-02
NEUMANN MARK
EVP, Chief Commercial Officer
D - Sale to Issuer
Performance Stock Units
-21,876
2
$13.67B
2025-04-02
2025-04-02
NEUMANN MARK
EVP, Chief Commercial Officer
D - Sale to Issuer
Restricted Stock Units
-53,345
3
$13.67B
2025-04-02
2025-04-02
NEUMANN MARK
EVP, Chief Commercial Officer
D - Sale to Issuer
Stock Option (right to buy)
-17,916
1
$13.67B
2025-04-02
2025-04-02
NEUMANN MARK
EVP, Chief Commercial Officer
D - Sale to Issuer
Common Stock
-52,811
$132.00
-6.97M
1
$13.67B
2025-04-02
2025-04-02
RIGGS RORY
D - Sale to Issuer
Restricted Stock Units
-2,951
1
$13.67B
2025-04-02
2025-04-02
RIGGS RORY
D - Sale to Issuer
Stock Option (right to buy)
-108K
7
$13.67B
2025-04-02
2025-04-02
SALAS EDUARDO RENE
D - Sale to Issuer
Restricted Stock Units
-2,951
1
$13.67B
2025-04-02
2025-04-02
SALAS EDUARDO RENE
D - Sale to Issuer
Stock Option (right to buy)
-48,088
4
$13.67B
2025-04-02
2025-04-02
VAN NOSTRAND ROBERT
D - Sale to Issuer
Restricted Stock Units
-2,951
1
$13.67B
2025-04-02
2025-04-02
VAN NOSTRAND ROBERT
D - Sale to Issuer
Stock Option (right to buy)
-128K
8
$13.67B
2025-04-02
2025-04-02
VAN NOSTRAND ROBERT
D - Sale to Issuer
Common Stock
-11,340
$132.00
-1.50M
1
$13.67B
2025-04-02
2025-04-02
MATES SHARON
Chairman and CEO
D - Sale to Issuer
Stock Option (right to buy)
-530K
6
$13.67B
2025-04-02
2025-04-02
MATES SHARON
Chairman and CEO
D - Sale to Issuer
Common Stock
-1.14M
$132.00
-150M
2
$13.67B
2025-04-02
2025-04-02
NARULA SANJEEV
Executive Vice President & CFO
D - Sale to Issuer
Restricted Stock Units
-57,773
2
$13.67B
2025-04-02
2025-04-02
NARULA SANJEEV
Executive Vice President & CFO
D - Sale to Issuer
Stock Option (right to buy)
-17,251
1
$13.67B
2025-04-02
2025-04-02
NEUMANN MARK
EVP, Chief Commercial Officer
D - Sale to Issuer
Performance Stock Units
-21,876
2
$13.67B
2025-04-02
2025-04-02
NEUMANN MARK
EVP, Chief Commercial Officer
D - Sale to Issuer
Restricted Stock Units
-53,345
3
$13.67B
2025-04-02
2025-04-02
NEUMANN MARK
EVP, Chief Commercial Officer
D - Sale to Issuer
Stock Option (right to buy)
-17,916
1
$13.67B
2025-04-02
2025-04-02
NEUMANN MARK
EVP, Chief Commercial Officer
D - Sale to Issuer
Common Stock
-52,811
$132.00
-6.97M
1
$13.67B
2025-04-02
2025-04-02
RIGGS RORY
D - Sale to Issuer
Restricted Stock Units
-2,951
1
$13.67B
2025-04-02
2025-04-02
RIGGS RORY
D - Sale to Issuer
Stock Option (right to buy)
-108K
7
$13.67B
2025-04-02
2025-04-02
RIGGS RORY
D - Sale to Issuer
Common Stock
-132K
$132.00
-17M
1
$13.67B
2025-04-02
2025-04-02
SALAS EDUARDO RENE
D - Sale to Issuer
Restricted Stock Units
-2,951
1
$13.67B
2025-03-26
2025-03-31
MATES SHARON
Chairman and CEO
G - Gift
Common Stock
-190K
$0.00
1
$13.67B
2025-03-26
2025-03-31
MATES SHARON
Chairman and CEO
G - Gift
Common Stock
190K
$0.00
1
$13.67B
2025-03-18
2025-03-18
ALEXANDRIA VENTURE INVESTMENTS LLC
S - Sale
-20,000
$131.00
-2.62M
1
$13.67B
2025-03-17
2025-03-17
ALEXANDRIA VENTURE INVESTMENTS LLC
S - Sale
-11,750
$131.00
-1.54M
1
$13.67B
2025-03-10
2025-03-10
DURGAM SURESH
EVP, Chief Medical Officer
M - Exercise
Common Stock
7,345
1
$13.67B
2025-03-10
2025-03-10
HALSTEAD MICHAEL
President
M - Exercise
Restricted Stock Units
-7,345
$0.00
1
$13.67B
2025-03-10
2025-03-10
HALSTEAD MICHAEL
President
M - Exercise
Common Stock
7,345
1
$13.67B
2025-03-10
2025-03-10
MATES SHARON
Chairman and CEO
M - Exercise
Restricted Stock Units
-20,566
$0.00
1
$13.67B
2025-03-10
2025-03-10
HALSTEAD MICHAEL
President
F - Tax
Common Stock
-3,757
$131.00
-492K
1
$13.67B
2025-03-10
2025-03-10
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Restricted Stock Units
-7,345
$0.00
1
$13.67B
2025-03-10
2025-03-10
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Common Stock
7,345
1
$13.67B
2025-03-10
2025-03-10
DURGAM SURESH
EVP, Chief Medical Officer
F - Tax
Common Stock
-3,116
$131.00
-408K
1
$13.67B
2025-03-10
2025-03-10
MATES SHARON
Chairman and CEO
M - Exercise
Common Stock
20,566
1
$13.67B
2025-03-10
2025-03-10
MATES SHARON
Chairman and CEO
F - Tax
Common Stock
-10,129
$131.00
-1.33M
1
$13.67B
2025-03-10
2025-03-10
NEUMANN MARK
EVP, Chief Commercial Officer
F - Tax
Common Stock
-3,116
$131.00
-408K
1
$13.67B
2025-03-10
2025-03-10
DURGAM SURESH
EVP, Chief Medical Officer
M - Exercise
Restricted Stock Units
-7,345
$0.00
1
$13.67B
2025-03-06
2025-03-10
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Restricted Stock Units
-13,133
$0.00
1
$13.67B
2025-03-06
2025-03-10
DURGAM SURESH
EVP, Chief Medical Officer
F - Tax
Common Stock
-5,572
$131.00
-730K
1
$13.67B
2025-03-06
2025-03-10
HALSTEAD MICHAEL
President
F - Tax
Common Stock
-6,718
$131.00
-880K
1
$13.67B
2025-03-06
2025-03-10
MATES SHARON
Chairman and CEO
F - Tax
Common Stock
-19,848
$131.00
-2.60M
1
$13.67B
2025-03-06
2025-03-10
NEUMANN MARK
EVP, Chief Commercial Officer
F - Tax
Common Stock
-5,572
$131.00
-730K
1
$13.67B
2025-03-06
2025-03-10
DURGAM SURESH
EVP, Chief Medical Officer
M - Exercise
Restricted Stock Units
-13,133
$0.00
1
$13.67B
2025-03-06
2025-03-10
DURGAM SURESH
EVP, Chief Medical Officer
M - Exercise
Common Stock
13,133
1
$13.67B
2025-03-06
2025-03-10
HALSTEAD MICHAEL
President
M - Exercise
Restricted Stock Units
-13,133
$0.00
1
$13.67B
2025-03-06
2025-03-10
HALSTEAD MICHAEL
President
M - Exercise
Common Stock
13,133
1
$13.67B
2025-03-06
2025-03-10
MATES SHARON
Chairman and CEO
M - Exercise
Restricted Stock Units
-40,712
$0.00
1
$13.67B
2025-03-06
2025-03-10
MATES SHARON
Chairman and CEO
M - Exercise
Common Stock
40,712
1
$13.67B
2025-03-06
2025-03-10
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Common Stock
13,133
1
$13.67B
2025-03-01
2025-03-04
DURGAM SURESH
EVP, Chief Medical Officer
M - Exercise
Common Stock
8,742
1
$13.67B
2025-03-01
2025-03-04
HALSTEAD MICHAEL
President
M - Exercise
Common Stock
12,239
1
$13.67B
2025-03-01
2025-03-04
MATES SHARON
Chairman and CEO
M - Exercise
Restricted Stock Units
-34,969
$0.00
1
$13.67B
2025-03-01
2025-03-04
MATES SHARON
Chairman and CEO
M - Exercise
Common Stock
34,969
1
$13.67B
2025-03-01
2025-03-04
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Restricted Stock Units
-8,742
$0.00
1
$13.67B
2025-03-01
2025-03-04
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Common Stock
8,742
1
$13.67B
2025-03-01
2025-03-04
DURGAM SURESH
EVP, Chief Medical Officer
F - Tax
Common Stock
-3,709
$128.00
-475K
1
$13.67B
2025-03-01
2025-03-04
HALSTEAD MICHAEL
President
F - Tax
Common Stock
-6,261
$128.00
-801K
1
$13.67B
2025-03-01
2025-03-04
MATES SHARON
Chairman and CEO
F - Tax
Common Stock
-16,978
$128.00
-2.17M
1
$13.67B
2025-03-01
2025-03-04
NEUMANN MARK
EVP, Chief Commercial Officer
F - Tax
Common Stock
-3,709
$128.00
-475K
1
$13.67B
2025-03-01
2025-03-04
DURGAM SURESH
EVP, Chief Medical Officer
M - Exercise
Restricted Stock Units
-8,742
$0.00
1
$13.67B
2025-03-01
2025-03-04
HALSTEAD MICHAEL
President
M - Exercise
Restricted Stock Units
-12,239
$0.00
1
$13.67B
2025-02-24
2025-02-26
MARCUS JOEL
M - Exercise
Common Stock
7,009
$64.00
449K
1
$13.67B
2025-02-24
2025-02-26
MARCUS JOEL
M - Exercise
Stock Option (right to buy)
-7,009
$0.00
1
$13.67B
2025-02-03
2025-02-04
NARULA SANJEEV
Executive Vice President & CFO
A - Grant
Restricted Stock Units
22,727
$0.00
1
$13.67B
2025-02-03
2025-02-04
MATES SHARON
Chairman and CEO
A - Grant
Restricted Stock Units
121K
$0.00
1
$13.67B
2025-02-03
2025-02-04
NEUMANN MARK
EVP, Chief Commercial Officer
A - Grant
Restricted Stock Units
22,727
$0.00
1
$13.67B
2025-02-03
2025-02-04
DURGAM SURESH
EVP, Chief Medical Officer
A - Grant
Restricted Stock Units
24,621
$0.00
1
$13.67B
2025-02-03
2025-02-04
HALSTEAD MICHAEL
President
A - Grant
Restricted Stock Units
45,454
$0.00
1
$13.67B
2025-01-31
2025-02-04
HALSTEAD MICHAEL
President
A - Grant
Common Stock
11,017
$0.00
1
$13.67B
2025-01-31
2025-02-04
DURGAM SURESH
EVP, Chief Medical Officer
A - Grant
Common Stock
11,017
$0.00
1
$13.67B
2025-01-31
2025-02-04
HALSTEAD MICHAEL
President
A - Grant
Common Stock
11,017
$0.00
1
$13.67B
2025-01-31
2025-02-04
MATES SHARON
Chairman and CEO
A - Grant
Common Stock
30,847
$0.00
1
$13.67B
2025-01-31
2025-02-04
NEUMANN MARK
EVP, Chief Commercial Officer
A - Grant
Common Stock
11,017
$0.00
1
$13.67B
2025-01-31
2025-02-04
HALSTEAD MICHAEL
President
F - Tax
Common Stock
-5,691
$127.00
-723K
1
$13.67B
2025-01-31
2025-02-04
MATES SHARON
Chairman and CEO
F - Tax
Common Stock
-15,233
$127.00
-1.93M
1
$13.67B
2025-01-31
2025-02-04
NEUMANN MARK
EVP, Chief Commercial Officer
F - Tax
Common Stock
-4,729
$127.00
-601K
1
$13.67B
2025-01-31
2025-02-04
DURGAM SURESH
EVP, Chief Medical Officer
F - Tax
Common Stock
-4,730
$127.00
-601K
1
$13.67B
2025-01-31
2025-02-04
HALSTEAD MICHAEL
President
F - Tax
Common Stock
-5,691
$127.00
-723K
1
$13.67B
2025-01-31
2025-02-04
MATES SHARON
Chairman and CEO
F - Tax
Common Stock
-15,233
$127.00
-1.93M
1
$13.67B
2025-01-31
2025-02-04
NEUMANN MARK
EVP, Chief Commercial Officer
F - Tax
Common Stock
-4,729
$127.00
-601K
1
$13.67B
2025-01-31
2025-02-04
DURGAM SURESH
EVP, Chief Medical Officer
A - Grant
Common Stock
11,017
$0.00
1
$13.67B
2025-01-31
2025-02-04
MATES SHARON
Chairman and CEO
A - Grant
Common Stock
30,847
$0.00
1
$13.67B
2025-01-31
2025-02-04
NEUMANN MARK
EVP, Chief Commercial Officer
A - Grant
Common Stock
11,017
$0.00
1
$13.67B
2025-01-31
2025-02-04
DURGAM SURESH
EVP, Chief Medical Officer
F - Tax
Common Stock
-4,730
$127.00
-601K
1
$13.67B
2024-12-31
2025-01-03
RIGGS RORY
A - Grant
Common Stock
215
$84.00
18,060
1
$13.67B
2024-12-05
2024-12-06
MATES SHARON
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-51,697
$0.00
1
$13.67B
2024-12-05
2024-12-06
MATES SHARON
Chairman and CEO
M - Exercise
Common Stock
51,697
$13.00
672K
1
$13.67B
2024-12-05
2024-12-06
MATES SHARON
Chairman and CEO
S - Sale
Common Stock
-51,697
$84.00
-4.34M
2
$13.67B
2024-12-04
2024-12-06
MATES SHARON
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-51,000
$0.00
1
$13.67B
2024-12-04
2024-12-06
MATES SHARON
Chairman and CEO
S - Sale
Common Stock
-51,000
$86.00
-4.39M
2
$13.67B
2024-12-04
2024-12-06
MATES SHARON
Chairman and CEO
M - Exercise
Common Stock
51,000
$13.00
663K
1
$13.67B
2024-11-13
2024-11-14
HALSTEAD MICHAEL
President
M - Exercise
Common Stock
18,714
$37.00
692K
1
$13.67B
2024-11-13
2024-11-14
HALSTEAD MICHAEL
President
M - Exercise
Stock Option (right to buy)
-18,714
$0.00
1
$13.67B
2024-11-13
2024-11-14
HALSTEAD MICHAEL
President
S - Sale
Common Stock
-18,714
$88.00
-1.65M
2
$13.67B
2024-11-12
2024-11-14
HALSTEAD MICHAEL
President
M - Exercise
Stock Option (right to buy)
-22,869
$0.00
1
$13.67B
2024-11-12
2024-11-14
HALSTEAD MICHAEL
President
M - Exercise
Common Stock
22,869
$24.00
549K
1
$13.67B
2024-11-12
2024-11-14
HALSTEAD MICHAEL
President
S - Sale
Common Stock
-22,869
$89.00
-2.04M
3
$13.67B
2024-11-12
2024-11-12
HALSTEAD MICHAEL
President
S - Sale
-41,583
$89.00
-3.70M
1
$13.67B
2019-06-18
2024-10-15
RIGGS RORY
M - Exercise
Restricted Stock Units
-14,189
$0.00
1
$13.67B
2019-06-18
2024-10-15
RIGGS RORY
M - Exercise
Common Stock
14,189
1
$13.67B
2024-09-30
2024-10-02
RIGGS RORY
A - Grant
Common Stock
246
$73.00
17,958
1
$13.67B
2024-09-06
2024-09-06
ALEXANDRIA VENTURE INVESTMENTS LLC
S - Sale
-25,000
$73.00
-1.82M
1
$13.67B
2024-08-30
2024-08-30
MATES SHARON
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-34,396
$0.00
1
$13.67B
2024-08-30
2024-08-30
MATES SHARON
Chairman and CEO
M - Exercise
Common Stock
34,396
$13.00
447K
1
$13.67B
2024-08-30
2024-08-30
MATES SHARON
Chairman and CEO
S - Sale
Common Stock
-34,396
$73.00
-2.51M
2
$13.67B
2024-08-29
2024-08-30
MATES SHARON
Chairman and CEO
S - Sale
Common Stock
-35,604
$73.00
-2.60M
2
$13.67B
2024-08-29
2024-08-30
MATES SHARON
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-35,604
$0.00
1
$13.67B
2024-08-29
2024-08-30
MATES SHARON
Chairman and CEO
M - Exercise
Common Stock
35,604
$13.00
463K
1
$13.67B
2024-08-28
2024-08-28
MATES SHARON
Chairman and CEO
S - Sale
Common Stock
-32,699
$73.00
-2.39M
2
$13.67B
2024-08-28
2024-08-28
MATES SHARON
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-32,699
$0.00
1
$13.67B
2024-08-28
2024-08-28
MATES SHARON
Chairman and CEO
M - Exercise
Common Stock
32,699
$18.00
589K
1
$13.67B
2024-08-27
2024-08-28
MATES SHARON
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-40,513
$0.00
1
$13.67B
2024-08-27
2024-08-28
MATES SHARON
Chairman and CEO
M - Exercise
Common Stock
40,513
$18.00
729K
1
$13.67B
2024-08-27
2024-08-28
MATES SHARON
Chairman and CEO
S - Sale
Common Stock
-40,513
$74.00
-3.00M
2
$13.67B
2024-08-26
2024-08-28
MATES SHARON
Chairman and CEO
M - Exercise
Common Stock
22,713
$18.00
409K
1
$13.67B
2024-08-26
2024-08-28
MATES SHARON
Chairman and CEO
S - Sale
Common Stock
-22,713
$75.00
-1.70M
1
$13.67B
2024-08-26
2024-08-28
MATES SHARON
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-22,713
$0.00
1
$13.67B
2024-08-23
2024-08-23
MATES SHARON
Chairman and CEO
S - Sale
Common Stock
-28,680
$74.00
-2.12M
1
$13.67B
2024-08-23
2024-08-23
MATES SHARON
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-28,680
$0.00
1
$13.67B
2024-08-23
2024-08-23
MATES SHARON
Chairman and CEO
M - Exercise
Common Stock
28,680
$18.00
516K
1
$13.67B
2024-08-22
2024-08-23
MATES SHARON
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-39,380
$0.00
1
$13.67B
2024-08-22
2024-08-23
MATES SHARON
Chairman and CEO
S - Sale
Common Stock
-39,380
$75.00
-2.95M
2
$13.67B
2024-08-22
2024-08-23
MATES SHARON
Chairman and CEO
M - Exercise
Common Stock
39,380
$18.00
709K
1
$13.67B
2024-08-21
2024-08-23
MATES SHARON
Chairman and CEO
S - Sale
Common Stock
-53,013
$76.00
-4.03M
4
$13.67B
2024-08-21
2024-08-23
MATES SHARON
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-53,013
$0.00
1
$13.67B
2024-08-21
2024-08-23
MATES SHARON
Chairman and CEO
M - Exercise
Common Stock
53,013
$18.00
954K
1
$13.67B
2024-08-16
2024-08-20
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Common Stock
18,714
$37.00
692K
1
$13.67B
2024-08-16
2024-08-20
NEUMANN MARK
EVP, Chief Commercial Officer
S - Sale
Common Stock
-18,714
$75.00
-1.40M
1
$13.67B
2024-08-16
2024-08-20
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Stock Option (right to buy)
-18,714
$0.00
1
$13.67B
2024-08-12
2024-08-14
NARULA SANJEEV
Executive Vice President & CFO
A - Grant
Stock Option (right to buy)
17,251
$0.00
1
$13.67B
2024-08-12
2024-08-14
NARULA SANJEEV
Executive Vice President & CFO
A - Grant
Restricted Stock Units
35,046
$0.00
1
$13.67B
2024-06-28
2024-07-02
RIGGS RORY
A - Grant
Common Stock
262
$68.00
17,816
1
$13.67B
2024-06-28
2024-07-02
VAN NOSTRAND ROBERT
A - Grant
Common Stock
83
$68.00
5,644
1
$13.67B
2024-06-24
2024-06-25
RIGGS RORY
M - Exercise
Stock Option (right to buy)
-20,000
$0.00
1
$13.67B
2024-06-24
2024-06-25
RIGGS RORY
S - Sale
Common Stock
-4,462
$76.00
-339K
1
$13.67B
2024-06-24
2024-06-25
RIGGS RORY
M - Exercise
Common Stock
20,000
$17.00
340K
1
$13.67B
2024-06-23
2024-06-25
SALAS EDUARDO RENE
M - Exercise
Restricted Stock Units
-1,567
$0.00
1
$13.67B
2024-06-23
2024-06-25
MARCUS JOEL
M - Exercise
Restricted Stock Units
-1,567
$0.00
1
$13.67B
2024-06-23
2024-06-25
MARCUS JOEL
M - Exercise
Common Stock
1,567
1
$13.67B
2024-06-23
2024-06-25
RIGGS RORY
M - Exercise
Restricted Stock Units
-1,567
$0.00
1
$13.67B
2024-06-23
2024-06-25
RIGGS RORY
M - Exercise
Common Stock
1,567
1
$13.67B
2024-06-23
2024-06-25
SALAS EDUARDO RENE
M - Exercise
Common Stock
1,567
1
$13.67B
2024-06-23
2024-06-25
VAN NOSTRAND ROBERT
M - Exercise
Restricted Stock Units
-1,567
$0.00
1
$13.67B
2024-06-23
2024-06-25
VAN NOSTRAND ROBERT
M - Exercise
Common Stock
1,567
1
$13.67B
2024-06-18
2024-06-21
VAN NOSTRAND ROBERT
M - Exercise
Stock Option (right to buy)
-20,000
$0.00
1
$13.67B
2024-06-18
2024-06-21
VAN NOSTRAND ROBERT
M - Exercise
Common Stock
20,000
$17.00
340K
1
$13.67B
2024-06-18
2024-06-21
VAN NOSTRAND ROBERT
S - Sale
Common Stock
-20,000
$76.00
-1.52M
2
$13.67B
2024-06-14
2024-06-18
MARCUS JOEL
A - Grant
Restricted Stock Units
2,951
$0.00
1
$13.67B
2024-06-14
2024-06-18
MARCUS JOEL
A - Grant
Stock Option (right to buy)
4,322
$0.00
1
$13.67B
2024-06-14
2024-06-18
RIGGS RORY
A - Grant
Restricted Stock Units
2,951
$0.00
1
$13.67B
2024-06-14
2024-06-18
RIGGS RORY
A - Grant
Stock Option (right to buy)
4,322
$0.00
1
$13.67B
2024-06-14
2024-06-18
SALAS EDUARDO RENE
A - Grant
Restricted Stock Units
2,951
$0.00
1
$13.67B
2024-06-14
2024-06-18
SALAS EDUARDO RENE
A - Grant
Stock Option (right to buy)
4,322
$0.00
1
$13.67B
2024-06-14
2024-06-18
VAN NOSTRAND ROBERT
A - Grant
Restricted Stock Units
2,951
$0.00
1
$13.67B
2024-06-14
2024-06-18
VAN NOSTRAND ROBERT
A - Grant
Stock Option (right to buy)
4,322
$0.00
1
$13.67B
2024-04-24
2024-04-25
MATES SHARON
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-20,020
$0.00
2
$13.67B
2024-04-24
2024-04-25
MATES SHARON
Chairman and CEO
M - Exercise
Common Stock
20,020
$17.00
340K
2
$13.67B
2024-03-31
2024-04-02
VAN NOSTRAND ROBERT
A - Grant
Common Stock
79
$69.00
5,451
1
$13.67B
2024-03-31
2024-04-02
RIGGS RORY
A - Grant
Common Stock
260
$69.00
17,940
1
$13.67B
2024-03-20
2024-03-22
RIGGS RORY
M - Exercise
Stock Option (right to buy)
-20,000
$0.00
1
$13.67B
2024-03-20
2024-03-22
RIGGS RORY
M - Exercise
Common Stock
20,000
$19.00
380K
1
$13.67B
2024-03-11
2024-03-11
MATES SHARON
Chairman, President & CEO
S - Sale
Common Stock
-20,565
$65.00
-1.34M
4
$13.67B
2024-03-11
2024-03-11
NEUMANN MARK
EVP, Chief Commercial Officer
S - Sale
Common Stock
-7,345
$66.00
-485K
3
$13.67B
2024-03-11
2024-03-11
DURGAM SURESH
EVP, Chief Medical Officer
S - Sale
Common Stock
-3,712
$66.00
-245K
3
$13.67B
2024-03-11
2024-03-11
HALSTEAD MICHAEL
EVP and General Counsel
S - Sale
Common Stock
-7,345
$66.00
-485K
2
$13.67B
2024-03-11
2024-03-11
HINELINE LAWRENCE
SVP of Finance, CFO
S - Sale
Common Stock
-10,121
$66.00
-668K
5
$13.67B
2024-03-10
2024-03-11
MATES SHARON
Chairman, President & CEO
M - Exercise
Restricted Stock Units
-20,565
$0.00
1
$13.67B
2024-03-10
2024-03-11
MATES SHARON
Chairman, President & CEO
M - Exercise
Common Stock
20,565
1
$13.67B
2024-03-10
2024-03-11
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Restricted Stock Units
-7,345
$0.00
1
$13.67B
2024-03-10
2024-03-11
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Common Stock
7,345
1
$13.67B
2024-03-10
2024-03-11
DURGAM SURESH
EVP, Chief Medical Officer
M - Exercise
Restricted Stock Units
-7,345
$0.00
1
$13.67B
2024-03-10
2024-03-11
DURGAM SURESH
EVP, Chief Medical Officer
M - Exercise
Common Stock
7,345
1
$13.67B
2024-03-10
2024-03-11
HALSTEAD MICHAEL
EVP and General Counsel
M - Exercise
Restricted Stock Units
-7,345
$0.00
1
$13.67B
2024-03-10
2024-03-11
HALSTEAD MICHAEL
EVP and General Counsel
M - Exercise
Common Stock
7,345
1
$13.67B
2024-03-10
2024-03-11
HINELINE LAWRENCE
SVP of Finance, CFO
M - Exercise
Restricted Stock Units
-5,582
$0.00
1
$13.67B
2024-03-10
2024-03-11
HINELINE LAWRENCE
SVP of Finance, CFO
M - Exercise
Stock Option (right to purchase)
-4,539
$0.00
1
$13.67B
2024-03-10
2024-03-11
HINELINE LAWRENCE
SVP of Finance, CFO
M - Exercise
Common Stock
10,121
$25.00
253K
2
$13.67B
2024-03-07
2024-03-11
DURGAM SURESH
EVP, Chief Medical Officer
S - Sale
Common Stock
-6,450
$67.00
-432K
2
$13.67B
2024-03-07
2024-03-11
NEUMANN MARK
EVP, Chief Commercial Officer
S - Sale
Common Stock
-13,132
$67.00
-880K
2
$13.67B
2024-03-07
2024-03-11
MATES SHARON
Chairman, President & CEO
S - Sale
Common Stock
-40,712
$66.00
-2.69M
2
$13.67B
2024-03-07
2024-03-11
HINELINE LAWRENCE
SVP of Finance, CFO
S - Sale
Common Stock
-13,132
$67.00
-880K
2
$13.67B
2024-03-07
2024-03-11
HALSTEAD MICHAEL
EVP and General Counsel
S - Sale
Common Stock
-13,132
$66.00
-867K
2
$13.67B
2024-03-06
2024-03-08
DURGAM SURESH
EVP, Chief Medical Officer
M - Exercise
Restricted Stock Units
-13,132
$0.00
1
$13.67B
2024-03-06
2024-03-08
DURGAM SURESH
EVP, Chief Medical Officer
M - Exercise
Common Stock
13,132
1
$13.67B
2024-03-06
2024-03-08
HALSTEAD MICHAEL
EVP and General Counsel
M - Exercise
Restricted Stock Units
-13,132
$0.00
1
$13.67B
2024-03-06
2024-03-08
HALSTEAD MICHAEL
EVP and General Counsel
M - Exercise
Common Stock
13,132
1
$13.67B
2024-03-06
2024-03-08
HINELINE LAWRENCE
SVP of Finance, CFO
M - Exercise
Restricted Stock Units
-13,132
$0.00
1
$13.67B
2024-03-06
2024-03-08
HINELINE LAWRENCE
SVP of Finance, CFO
M - Exercise
Common Stock
13,132
1
$13.67B
2024-03-06
2024-03-08
MATES SHARON
Chairman, President & CEO
M - Exercise
Restricted Stock Units
-40,712
$0.00
1
$13.67B
2024-03-06
2024-03-08
MATES SHARON
Chairman, President & CEO
M - Exercise
Common Stock
40,712
1
$13.67B
2024-03-06
2024-03-08
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Restricted Stock Units
-13,132
$0.00
1
$13.67B
2024-03-06
2024-03-08
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Common Stock
13,132
1
$13.67B
2024-03-01
2024-03-05
DURGAM SURESH
EVP, Chief Medical Officer
A - Grant
Restricted Stock Units
26,227
$0.00
1
$13.67B
2024-03-01
2024-03-05
HALSTEAD MICHAEL
EVP and General Counsel
A - Grant
Restricted Stock Units
36,717
$0.00
1
$13.67B
2024-03-01
2024-03-05
HINELINE LAWRENCE
SVP of Finance, CFO
A - Grant
Restricted Stock Units
26,227
$0.00
1
$13.67B
2024-03-01
2024-03-05
MATES SHARON
Chairman, President & CEO
A - Grant
Restricted Stock Units
105K
$0.00
1
$13.67B
2024-03-01
2024-03-05
NEUMANN MARK
EVP, Chief Commercial Officer
A - Grant
Restricted Stock Units
26,227
$0.00
1
$13.67B
2024-02-27
2024-02-28
VAN NOSTRAND ROBERT
M - Exercise
Stock Option (right to buy)
-20,000
$0.00
1
$13.67B
2024-02-27
2024-02-28
VAN NOSTRAND ROBERT
M - Exercise
Common Stock
20,000
$19.00
380K
1
$13.67B
2024-02-27
2024-02-28
VAN NOSTRAND ROBERT
S - Sale
Common Stock
-20,000
$73.00
-1.46M
2
$13.67B
2024-02-26
2024-02-27
HINELINE LAWRENCE
SVP of Finance, CFO
M - Exercise
Common Stock
5,882
$37.00
218K
1
$13.67B
2024-02-26
2024-02-27
NEUMANN MARK
EVP, Chief Commercial Officer
S - Sale
Common Stock
-7,907
$70.00
-553K
4
$13.67B
2024-02-26
2024-02-27
MATES SHARON
Chairman, President & CEO
S - Sale
Common Stock
-22,590
$70.00
-1.58M
3
$13.67B
2024-02-26
2024-02-27
MARCUS JOEL
S - Sale
Common Stock
-26,328
$69.00
-1.82M
3
$13.67B
2024-02-26
2024-02-27
HINELINE LAWRENCE
SVP of Finance, CFO
S - Sale
Common Stock
-13,337
$69.00
-920K
5
$13.67B
2024-02-26
2024-02-27
HALSTEAD MICHAEL
EVP and General Counsel
S - Sale
Common Stock
-7,907
$70.00
-553K
3
$13.67B
2024-02-26
2024-02-27
DURGAM SURESH
EVP, Chief Medical Officer
S - Sale
Common Stock
-4,112
$70.00
-288K
3
$13.67B
2024-02-26
2024-02-27
MARCUS JOEL
M - Exercise
Common Stock
36,757
$49.00
1.80M
2
$13.67B
2024-02-26
2024-02-27
MARCUS JOEL
M - Exercise
Stock Option (right to buy)
-36,757
$0.00
2
$13.67B
2024-02-26
2024-02-27
HINELINE LAWRENCE
SVP of Finance, CFO
M - Exercise
Stock Option (right to buy)
-5,882
$0.00
1
$13.67B
2024-02-23
2024-02-27
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Restricted Stock Units
-7,907
$0.00
1
$13.67B
2024-02-23
2024-02-27
DURGAM SURESH
EVP, Chief Medical Officer
M - Exercise
Restricted Stock Units
-7,907
$0.00
1
$13.67B
2024-02-23
2024-02-27
DURGAM SURESH
EVP, Chief Medical Officer
M - Exercise
Common Stock
7,907
1
$13.67B
2024-02-23
2024-02-27
HALSTEAD MICHAEL
EVP and General Counsel
M - Exercise
Restricted Stock Units
-7,907
$0.00
1
$13.67B
2024-02-23
2024-02-27
HALSTEAD MICHAEL
EVP and General Counsel
M - Exercise
Common Stock
7,907
1
$13.67B
2024-02-23
2024-02-27
HINELINE LAWRENCE
SVP of Finance, CFO
M - Exercise
Restricted Stock Units
-7,455
$0.00
1
$13.67B
2024-02-23
2024-02-27
HINELINE LAWRENCE
SVP of Finance, CFO
M - Exercise
Common Stock
7,455
1
$13.67B
2024-02-23
2024-02-27
MATES SHARON
Chairman, President & CEO
M - Exercise
Restricted Stock Units
-22,590
$0.00
1
$13.67B
2024-02-23
2024-02-27
MATES SHARON
Chairman, President & CEO
M - Exercise
Common Stock
22,590
1
$13.67B
2024-02-23
2024-02-27
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Common Stock
7,907
1
$13.67B
2024-02-02
2024-02-05
DURGAM SURESH
EVP, Chief Medical Officer
S - Sale
Common Stock
-6,167
$67.00
-413K
2
$13.67B
2024-02-02
2024-02-05
HALSTEAD MICHAEL
EVP and General Counsel
S - Sale
Common Stock
-11,860
$66.00
-783K
2
$13.67B
2024-02-02
2024-02-05
HINELINE LAWRENCE
SVP of Finance, CFO
S - Sale
Common Stock
-11,183
$67.00
-749K
2
$13.67B
2024-02-02
2024-02-05
MATES SHARON
Chairman, President & CEO
S - Sale
Common Stock
-33,885
$67.00
-2.27M
2
$13.67B
2024-02-02
2024-02-05
NEUMANN MARK
EVP, Chief Commercial Officer
S - Sale
Common Stock
-11,860
$67.00
-795K
2
$13.67B
2024-02-01
2024-02-05
HALSTEAD MICHAEL
EVP and General Counsel
A - Grant
Common Stock
11,860
$0.00
1
$13.67B
2024-02-01
2024-02-05
DURGAM SURESH
EVP, Chief Medical Officer
A - Grant
Common Stock
11,860
$0.00
1
$13.67B
2024-02-01
2024-02-05
HINELINE LAWRENCE
SVP of Finance, CFO
A - Grant
Common Stock
11,183
$0.00
1
$13.67B
2024-02-01
2024-02-05
MATES SHARON
Chairman, President & CEO
A - Grant
Common Stock
33,885
$0.00
1
$13.67B
2024-02-01
2024-02-05
NEUMANN MARK
EVP, Chief Commercial Officer
A - Grant
Common Stock
11,860
$0.00
1
$13.67B
2024-02-02
2024-02-02
HALSTEAD MICHAEL
President
S - Sale
-33,885
$67.00
-2.27M
1
$13.67B
2024-01-18
2024-01-18
MATES SHARON
Chairman, President & CEO
S - Sale
Common Stock
-67,917
$65.00
-4.41M
2
$13.67B
2024-01-18
2024-01-18
MATES SHARON
Chairman, President & CEO
M - Exercise
Stock Option (right to buy)
-67,917
$0.00
1
$13.67B
2024-01-18
2024-01-18
MATES SHARON
Chairman, President & CEO
M - Exercise
Common Stock
67,917
$17.00
1.15M
1
$13.67B
2024-01-17
2024-01-18
MATES SHARON
Chairman, President & CEO
S - Sale
Common Stock
-48,084
$66.00
-3.17M
2
$13.67B
2024-01-17
2024-01-18
MATES SHARON
Chairman, President & CEO
M - Exercise
Stock Option (right to buy)
-48,084
$0.00
1
$13.67B
2024-01-17
2024-01-18
MATES SHARON
Chairman, President & CEO
M - Exercise
Common Stock
48,084
$17.00
817K
1
$13.67B
2024-01-16
2024-01-18
MATES SHARON
Chairman, President & CEO
S - Sale
Common Stock
-75,361
$67.00
-5.05M
3
$13.67B
2024-01-16
2024-01-18
MATES SHARON
Chairman, President & CEO
M - Exercise
Stock Option (right to buy)
-75,361
$0.00
1
$13.67B
2024-01-16
2024-01-18
MATES SHARON
Chairman, President & CEO
M - Exercise
Common Stock
75,361
$17.00
1.28M
1
$13.67B
2024-01-16
2024-01-16
MATES SHARON
Chairman and CEO
S - Sale
-191K
$67.00
-13M
1
$13.67B
2024-01-11
2024-01-12
HALSTEAD MICHAEL
EVP and General Counsel
M - Exercise
Stock Option (right to buy)
-50,000
$0.00
2
$13.67B
2024-01-11
2024-01-12
HALSTEAD MICHAEL
EVP and General Counsel
M - Exercise
Common Stock
50,000
$14.00
700K
2
$13.67B
2024-01-11
2024-01-12
HALSTEAD MICHAEL
EVP and General Counsel
S - Sale
Common Stock
-50,000
$67.00
-3.35M
3
$13.67B
2024-01-02
2024-01-04
DURGAM SURESH
EVP, Chief Medical Officer
M - Exercise
Stock Option (right to buy)
-62,282
$0.00
1
$13.67B
2024-01-02
2024-01-04
DURGAM SURESH
EVP, Chief Medical Officer
M - Exercise
Common Stock
62,282
$20.00
1.25M
1
$13.67B
2024-01-02
2024-01-04
DURGAM SURESH
EVP, Chief Medical Officer
S - Sale
Common Stock
-62,282
$71.00
-4.42M
3
$13.67B
2023-12-31
2024-01-03
RIGGS RORY
A - Grant
Common Stock
251
$72.00
18,072
1
$13.67B
2023-12-31
2024-01-03
VAN NOSTRAND ROBERT
A - Grant
Common Stock
76
$72.00
5,472
1
$13.67B
2023-12-13
2023-12-15
DURGAM SURESH
EVP, Chief Medical Officer
S - Sale
Common Stock
-21,262
$65.00
-1.38M
1
$13.67B
2023-12-01
2023-12-01
ALEXANDRIA VENTURE INVESTMENTS LLC
S - Sale
-55,000
$62.00
-3.41M
1
$13.67B
2023-11-13
2023-11-14
HALSTEAD MICHAEL
EVP and General Counsel
S - Sale
Common Stock
-50,000
$54.00
-2.70M
2
$13.67B
2023-11-13
2023-11-14
HALSTEAD MICHAEL
EVP and General Counsel
M - Exercise
Stock Option (right to buy)
-50,000
$0.00
2
$13.67B
2023-11-13
2023-11-14
HALSTEAD MICHAEL
EVP and General Counsel
M - Exercise
Common Stock
50,000
$14.00
700K
2
$13.67B
2023-11-06
2023-11-08
NEUMANN MARK
EVP, Chief Commercial Officer
S - Sale
Common Stock
-42,393
$56.00
-2.37M
2
$13.67B
2023-11-06
2023-11-08
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Stock Option (right to buy)
-26,754
$0.00
1
$13.67B
2023-11-06
2023-11-08
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Common Stock
26,754
$24.00
642K
1
$13.67B
2023-11-06
2023-11-06
ALEXANDRIA VENTURE INVESTMENTS LLC
S - Sale
-23,000
$56.00
-1.29M
1
$13.67B
2023-09-30
2023-10-02
RIGGS RORY
A - Grant
Common Stock
345
$52.00
17,940
1
$13.67B
2023-09-30
2023-10-02
VAN NOSTRAND ROBERT
A - Grant
Common Stock
105
$52.00
5,460
1
$13.67B
2023-09-19
2023-09-19
MATES SHARON
Chairman, President & CEO
S - Sale
Common Stock
-44,413
$54.00
-2.40M
1
$13.67B
2023-09-18
2023-09-19
MATES SHARON
Chairman, President & CEO
S - Sale
Common Stock
-55,587
$54.00
-3.00M
2
$13.67B
2023-09-13
2023-09-13
ALEXANDRIA VENTURE INVESTMENTS LLC
S - Sale
-55,500
$58.00
-3.22M
1
$13.67B
2023-08-14
2023-08-14
ALEXANDRIA VENTURE INVESTMENTS LLC
S - Sale
-47,500
$58.00
-2.75M
1
$13.67B
2023-08-07
2023-08-09
NEUMANN MARK
EVP, Chief Commercial Officer
S - Sale
Common Stock
-55,300
$59.00
-3.26M
1
$13.67B
2023-08-07
2023-08-09
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Stock Option (right to buy)
-55,300
$0.00
1
$13.67B
2023-08-07
2023-08-09
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Common Stock
55,300
$19.00
1.05M
1
$13.67B
2023-07-17
2023-07-20
DURGAM SURESH
EVP, Chief Medical Officer
S - Sale
Common Stock
-1,842
$65.00
-120K
1
$13.67B
2016-01-04
2023-07-07
HALSTEAD MICHAEL
EVP and General Counsel
A - Grant
Stock Option (right to buy)
40,472
$0.00
1
$13.67B
2016-01-04
2023-07-07
HINELINE LAWRENCE
SVP of Finance CFO
A - Grant
Stock Option (right to buy)
40,472
$0.00
1
$13.67B
2016-01-04
2023-07-07
MATES SHARON
Chairman, President & CEO
A - Grant
Stock Option (right to buy)
86,003
$0.00
1
$13.67B
2023-06-30
2023-07-05
RIGGS RORY
A - Grant
Common Stock
279
$63.00
17,577
1
$13.67B
2023-06-30
2023-07-05
VAN NOSTRAND ROBERT
A - Grant
Common Stock
85
$63.00
5,355
1
$13.67B
2023-06-23
2023-06-27
SALAS EDUARDO RENE
A - Grant
Stock Option (right to buy)
7,009
$0.00
1
$13.67B
2023-06-23
2023-06-27
MARCUS JOEL
A - Grant
Restricted Stock Units
1,567
$0.00
1
$13.67B
2023-06-23
2023-06-27
MARCUS JOEL
A - Grant
Stock Option (right to buy)
7,009
$0.00
1
$13.67B
2023-06-23
2023-06-27
RIGGS RORY
A - Grant
Restricted Stock Units
1,567
$0.00
1
$13.67B
2023-06-23
2023-06-27
RIGGS RORY
A - Grant
Stock Option (right to buy)
7,009
$0.00
1
$13.67B
2023-06-23
2023-06-27
SALAS EDUARDO RENE
A - Grant
Restricted Stock Units
1,567
$0.00
1
$13.67B
2023-06-23
2023-06-27
VAN NOSTRAND ROBERT
A - Grant
Restricted Stock Units
1,567
$0.00
1
$13.67B
2023-06-23
2023-06-27
VAN NOSTRAND ROBERT
A - Grant
Stock Option (right to buy)
7,009
$0.00
1
$13.67B
2023-06-14
2023-06-16
HINELINE LAWRENCE
SVP of Finance CFO
S - Sale
Common Stock
-81,854
$64.00
-5.24M
3
$13.67B
2023-06-14
2023-06-16
HINELINE LAWRENCE
SVP of Finance CFO
M - Exercise
Stock Option (right to purchase)
-81,854
$0.00
4
$13.67B
2023-06-14
2023-06-16
HINELINE LAWRENCE
SVP of Finance CFO
M - Exercise
Common Stock
81,854
$42.00
3.44M
4
$13.67B
2023-04-17
2023-04-19
VAN NOSTRAND ROBERT
S - Sale
Common Stock
-10,000
$63.00
-630K
1
$13.67B
2023-04-17
2023-04-19
VAN NOSTRAND ROBERT
M - Exercise
Stock Option (right to buy)
-10,000
$0.00
1
$13.67B
2023-04-17
2023-04-19
VAN NOSTRAND ROBERT
M - Exercise
Common Stock
10,000
$13.00
130K
1
$13.67B
2023-03-31
2023-04-04
RIGGS RORY
A - Grant
Common Stock
313
$54.00
16,902
1
$13.67B
2023-03-31
2023-04-04
VAN NOSTRAND ROBERT
A - Grant
Common Stock
95
$54.00
5,130
1
$13.67B
2023-03-28
2023-03-30
NEUMANN MARK
EVP, Chief Commercial Officer
S - Sale
Common Stock
-15,604
$54.00
-843K
2
$13.67B
2023-03-13
2023-03-13
DURGAM SURESH
EVP, Chief Medical Officer
S - Sale
Common Stock
-7,344
$45.00
-330K
2
$13.67B
2023-03-13
2023-03-13
MATES SHARON
Chairman, President & CEO
M - Exercise
Stock Option (right to buy)
-20,000
$0.00
1
$13.67B
2023-03-13
2023-03-13
MATES SHARON
Chairman, President & CEO
M - Exercise
Common Stock
20,000
$3.00
60,000
1
$13.67B
2023-03-13
2023-03-13
NEUMANN MARK
EVP, Chief Commercial Officer
S - Sale
Common Stock
-3,758
$45.00
-169K
2
$13.67B
2023-03-13
2023-03-13
MATES SHARON
Chairman, President & CEO
S - Sale
Common Stock
-20,565
$45.00
-925K
2
$13.67B
2023-03-13
2023-03-13
HINELINE LAWRENCE
SVP of Finance CFO
S - Sale
Common Stock
-5,582
$45.00
-251K
2
$13.67B
2023-03-13
2023-03-13
HALSTEAD MICHAEL
EVP and General Counsel
S - Sale
Common Stock
-7,344
$45.00
-330K
2
$13.67B
2023-03-10
2023-03-13
HALSTEAD MICHAEL
EVP and General Counsel
M - Exercise
Common Stock
7,344
1
$13.67B
2023-03-10
2023-03-13
HALSTEAD MICHAEL
EVP and General Counsel
S - Sale
Common Stock
-16,708
$43.00
-718K
2
$13.67B
2023-03-10
2023-03-13
HINELINE LAWRENCE
SVP of Finance CFO
S - Sale
Common Stock
-15,663
$43.00
-674K
2
$13.67B
2023-03-10
2023-03-13
MATES SHARON
Chairman, President & CEO
S - Sale
Common Stock
-41,770
$43.00
-1.80M
2
$13.67B
2023-03-10
2023-03-13
NEUMANN MARK
EVP, Chief Commercial Officer
S - Sale
Common Stock
-8,550
$43.00
-368K
2
$13.67B
2023-03-10
2023-03-13
DURGAM SURESH
EVP, Chief Medical Officer
M - Exercise
Restricted Stock Units
-7,344
$0.00
1
$13.67B
2023-03-10
2023-03-13
DURGAM SURESH
EVP, Chief Medical Officer
M - Exercise
Common Stock
7,344
1
$13.67B
2023-03-10
2023-03-13
HALSTEAD MICHAEL
EVP and General Counsel
M - Exercise
Restricted Stock Units
-7,344
$0.00
1
$13.67B
2023-03-10
2023-03-13
HINELINE LAWRENCE
SVP of Finance CFO
M - Exercise
Restricted Stock Units
-5,582
$0.00
1
$13.67B
2023-03-10
2023-03-13
HINELINE LAWRENCE
SVP of Finance CFO
M - Exercise
Common Stock
5,582
1
$13.67B
2023-03-10
2023-03-13
MATES SHARON
Chairman, President & CEO
M - Exercise
Restricted Stock Units
-20,565
$0.00
1
$13.67B
2023-03-10
2023-03-13
MATES SHARON
Chairman, President & CEO
M - Exercise
Common Stock
20,565
1
$13.67B
2023-03-10
2023-03-13
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Restricted Stock Units
-7,344
$0.00
1
$13.67B
2023-03-10
2023-03-13
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Common Stock
7,344
1
$13.67B
2023-03-09
2023-03-13
MATES SHARON
Chairman, President & CEO
A - Grant
Common Stock
41,770
$0.00
1
$13.67B
2023-03-09
2023-03-13
HINELINE LAWRENCE
SVP of Finance CFO
A - Grant
Common Stock
15,663
$0.00
1
$13.67B
2023-03-09
2023-03-13
HALSTEAD MICHAEL
EVP and General Counsel
A - Grant
Common Stock
16,708
$0.00
1
$13.67B
2023-03-09
2023-03-13
NEUMANN MARK
EVP, Chief Commercial Officer
A - Grant
Common Stock
16,708
$0.00
1
$13.67B
2023-03-06
2023-03-08
HINELINE LAWRENCE
SVP of Finance CFO
A - Grant
Restricted Stock Units
39,398
$0.00
1
$13.67B
2023-03-06
2023-03-08
NEUMANN MARK
EVP, Chief Commercial Officer
A - Grant
Restricted Stock Units
39,398
$0.00
1
$13.67B
2023-03-06
2023-03-08
MATES SHARON
Chairman, President & CEO
A - Grant
Restricted Stock Units
122K
$0.00
1
$13.67B
2023-03-06
2023-03-08
DURGAM SURESH
EVP, Chief Medical Officer
A - Grant
Restricted Stock Units
39,398
$0.00
1
$13.67B
2023-03-06
2023-03-08
HALSTEAD MICHAEL
EVP and General Counsel
A - Grant
Restricted Stock Units
39,398
$0.00
1
$13.67B
2023-03-01
2023-03-03
NEUMANN MARK
EVP, Chief Commercial Officer
S - Sale
Common Stock
-7,241
$50.00
-362K
1
$13.67B
2023-02-24
2023-02-27
MATES SHARON
Chairman, President & CEO
M - Exercise
Common Stock
30,000
$3.00
90,000
1
$13.67B
2023-02-24
2023-02-27
DURGAM SURESH
SVP, Chief Medical Officer
S - Sale
Common Stock
-7,906
$47.00
-372K
1
$13.67B
2023-02-24
2023-02-27
HALSTEAD MICHAEL
EVP and General Counsel
S - Sale
Common Stock
-7,906
$47.00
-372K
1
$13.67B
2023-02-24
2023-02-27
HINELINE LAWRENCE
SVP of Finance CFO
S - Sale
Common Stock
-7,455
$47.00
-350K
1
$13.67B
2023-02-24
2023-02-27
MATES SHARON
Chairman, President & CEO
S - Sale
Common Stock
-22,590
$47.00
-1.06M
1
$13.67B
2023-02-24
2023-02-27
NEUMANN MARK
EVP, Chief Commercial Officer
S - Sale
Common Stock
-4,046
$47.00
-190K
1
$13.67B
2023-02-24
2023-02-27
MATES SHARON
Chairman, President & CEO
M - Exercise
Stock Option (right to buy)
-30,000
$0.00
1
$13.67B
2023-02-23
2023-02-27
HALSTEAD MICHAEL
EVP and General Counsel
M - Exercise
Restricted Stock Units
-7,906
$0.00
1
$13.67B
2023-02-23
2023-02-27
HALSTEAD MICHAEL
EVP and General Counsel
M - Exercise
Common Stock
7,906
1
$13.67B
2023-02-23
2023-02-27
HINELINE LAWRENCE
SVP of Finance CFO
M - Exercise
Restricted Stock Units
-7,455
$0.00
1
$13.67B
2023-02-23
2023-02-27
HINELINE LAWRENCE
SVP of Finance CFO
M - Exercise
Common Stock
7,455
1
$13.67B
2023-02-23
2023-02-27
MATES SHARON
Chairman, President & CEO
M - Exercise
Restricted Stock Units
-22,590
$0.00
1
$13.67B
2023-02-23
2023-02-27
MATES SHARON
Chairman, President & CEO
M - Exercise
Common Stock
22,590
1
$13.67B
2023-02-23
2023-02-27
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Restricted Stock Units
-7,906
$0.00
1
$13.67B
2023-02-23
2023-02-27
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Common Stock
7,906
1
$13.67B
2023-02-23
2023-02-27
DURGAM SURESH
SVP, Chief Medical Officer
M - Exercise
Restricted Stock Units
-7,906
$0.00
1
$13.67B
2023-02-23
2023-02-27
DURGAM SURESH
SVP, Chief Medical Officer
M - Exercise
Common Stock
7,906
1
$13.67B
2023-02-21
2023-02-22
MATES SHARON
Chairman, President & CEO
S - Sale
Common Stock
-27,848
$47.00
-1.31M
4
$13.67B
2023-02-21
2023-02-22
DURGAM SURESH
SVP, Chief Medical Officer
S - Sale
Common Stock
-8,354
$47.00
-393K
4
$13.67B
2023-02-21
2023-02-22
HALSTEAD MICHAEL
EVP and General Counsel
S - Sale
Common Stock
-11,139
$47.00
-524K
4
$13.67B
2023-02-21
2023-02-22
HINELINE LAWRENCE
SVP of Finance CFO
S - Sale
Common Stock
-10,443
$47.00
-491K
4
$13.67B
2023-02-21
2023-02-22
NEUMANN MARK
EVP, Chief Commercial Officer
S - Sale
Common Stock
-3,898
$47.00
-183K
3
$13.67B
2023-02-18
2023-02-22
HINELINE LAWRENCE
SVP of Finance CFO
M - Exercise
Common Stock
10,443
1
$13.67B
2023-02-18
2023-02-22
DURGAM SURESH
SVP, Chief Medical Officer
M - Exercise
Restricted Stock Units
-8,354
$0.00
1
$13.67B
2023-02-18
2023-02-22
DURGAM SURESH
SVP, Chief Medical Officer
M - Exercise
Common Stock
8,354
1
$13.67B
2023-02-18
2023-02-22
HALSTEAD MICHAEL
EVP and General Counsel
M - Exercise
Restricted Stock Units
-11,139
$0.00
1
$13.67B
2023-02-18
2023-02-22
HALSTEAD MICHAEL
EVP and General Counsel
M - Exercise
Common Stock
11,139
1
$13.67B
2023-02-18
2023-02-22
HINELINE LAWRENCE
SVP of Finance CFO
M - Exercise
Restricted Stock Units
-10,443
$0.00
1
$13.67B
2023-02-18
2023-02-22
MATES SHARON
Chairman, President & CEO
M - Exercise
Restricted Stock Units
27,848
$0.00
1
$13.67B
2023-02-18
2023-02-22
MATES SHARON
Chairman, President & CEO
M - Exercise
Common Stock
27,848
1
$13.67B
2023-02-18
2023-02-22
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Restricted Stock Units
-11,139
$0.00
1
$13.67B
2023-02-18
2023-02-22
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Common Stock
11,139
1
$13.67B
2023-02-17
2023-02-22
HINELINE LAWRENCE
SVP of Finance CFO
M - Exercise
Common Stock
53,968
$13.00
702K
1
$13.67B
2023-02-17
2023-02-22
HINELINE LAWRENCE
SVP of Finance CFO
S - Sale
Common Stock
-53,968
$50.00
-2.70M
2
$13.67B
2023-02-17
2023-02-22
HINELINE LAWRENCE
SVP of Finance CFO
M - Exercise
Stock Option (right to buy)
-53,968
$0.00
1
$13.67B
2022-12-30
2023-01-03
VAN NOSTRAND ROBERT
A - Grant
Common Stock
97
$53.00
5,141
1
$13.67B
2022-12-30
2023-01-03
RIGGS RORY
A - Grant
Common Stock
321
$53.00
17,013
1
$13.67B
2022-12-19
2022-12-21
MARCUS JOEL
S - Sale
Common Stock
-5,000
$51.00
-255K
1
$13.67B
2022-12-13
2022-12-15
MATES SHARON
Chairman, President & CEO
S - Sale
Common Stock
-33,083
$55.00
-1.82M
1
$13.67B
2022-12-01
2022-12-02
HALSTEAD MICHAEL
EVP and General Counsel
M - Exercise
Stock Option (right to buy)
-50,000
$0.00
1
$13.67B
2022-12-01
2022-12-02
HALSTEAD MICHAEL
EVP and General Counsel
M - Exercise
Common Stock
50,000
$15.00
750K
1
$13.67B
2022-12-01
2022-12-02
HALSTEAD MICHAEL
EVP and General Counsel
S - Sale
Common Stock
-50,000
$54.00
-2.70M
2
$13.67B
2022-11-07
2022-11-08
MARCUS JOEL
S - Sale
Common Stock
-10,000
$52.00
-520K
2
$13.67B
2022-09-30
2022-10-05
VAN NOSTRAND ROBERT
A - Grant
Common Stock
110
$47.00
5,170
1
$13.67B
2022-09-30
2022-10-04
RIGGS RORY
A - Grant
Common Stock
365
$47.00
17,155
1
$13.67B
2022-09-21
2022-09-23
HINELINE LAWRENCE
SVP of Finance CFO
M - Exercise
Common Stock
65,164
$15.00
977K
1
$13.67B
2022-09-21
2022-09-23
HINELINE LAWRENCE
SVP of Finance CFO
S - Sale
Common Stock
-65,164
$46.00
-3.00M
2
$13.67B
2022-09-21
2022-09-23
HINELINE LAWRENCE
SVP of Finance CFO
M - Exercise
Stock Option (right to buy)
-65,164
$0.00
1
$13.67B
2022-08-11
2022-08-12
VAN NOSTRAND ROBERT
S - Sale
Common Stock
-30,000
$57.00
-1.71M
2
$13.67B
2022-08-11
2022-08-12
MARCUS JOEL
S - Sale
Common Stock
-10,000
$59.00
-590K
1
$13.67B
2022-08-11
2022-08-12
VAN NOSTRAND ROBERT
M - Exercise
Stock Option (right to buy)
-30,000
$0.00
2
$13.67B
2022-08-11
2022-08-12
VAN NOSTRAND ROBERT
M - Exercise
Common Stock
30,000
$13.00
390K
2
$13.67B
2022-06-30
2022-07-05
RIGGS RORY
A - Grant
Common Stock
289
$57.00
16,473
1
$13.67B
2022-06-30
2022-07-05
VAN NOSTRAND ROBERT
A - Grant
Common Stock
108
$57.00
6,156
1
$13.67B
2022-06-09
2022-06-13
RAWLINS MICHAEL
A - Grant
Stock Option (right to buy)
16,757
$0.00
1
$13.67B
2022-06-09
2022-06-13
RIGGS RORY
A - Grant
Stock Option (right to buy)
16,757
$0.00
1
$13.67B
2022-06-09
2022-06-13
VAN NOSTRAND ROBERT
A - Grant
Stock Option (right to buy)
16,757
$0.00
1
$13.67B
2022-06-09
2022-06-13
SALAS EDUARDO RENE
A - Grant
Stock Option (right to buy)
16,757
$0.00
1
$13.67B
2022-06-09
2022-06-13
MARCUS JOEL
A - Grant
Stock Option (right to buy)
16,757
$0.00
1
$13.67B
2022-05-12
2022-05-13
MARCUS JOEL
S - Sale
Common Stock
-10,000
$55.00
-550K
1
$13.67B
2019-06-18
2022-05-13
MARCUS JOEL
M - Exercise
Restricted Stock Units
-14,189
$0.00
1
$13.67B
2019-06-18
2022-05-13
MARCUS JOEL
M - Exercise
Common Stock
14,189
1
$13.67B
2022-04-20
2022-04-21
SALAS EDUARDO RENE
A - Grant
Stock Option (right to buy)
20,000
$0.00
1
$13.67B
2022-04-08
2022-04-08
NEUMANN MARK
EVP, Chief Commercial Officer
S - Sale
Common Stock
-86,348
$64.00
-5.53M
3
$13.67B
2022-04-08
2022-04-08
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Common Stock
86,348
$13.00
1.12M
1
$13.67B
2022-04-08
2022-04-08
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Stock Option (right to buy)
-86,348
$0.00
1
$13.67B
2022-03-31
2022-04-04
VAN NOSTRAND ROBERT
A - Grant
Common Stock
126
$61.00
7,686
1
$13.67B
2022-03-31
2022-04-04
RIGGS RORY
A - Grant
Common Stock
257
$61.00
15,677
1
$13.67B
2022-03-18
2022-03-18
RIGGS RORY
S - Sale
Common Stock
-20,637
$61.00
-1.26M
2
$13.67B
2022-03-17
2022-03-18
RIGGS RORY
S - Sale
Common Stock
-141K
$60.00
-8.49M
2
$13.67B
2022-03-16
2022-03-18
RIGGS RORY
S - Sale
Common Stock
-64,534
$59.00
-3.81M
2
$13.67B
2022-03-10
2022-03-14
MATES SHARON
Chairman, President & CEO
A - Grant
Restricted Stock Units
61,696
$0.00
1
$13.67B
2022-03-10
2022-03-14
DURGAM SURESH
Chief Medical Officer
A - Grant
Restricted Stock Units
22,034
$0.00
1
$13.67B
2022-03-10
2022-03-14
DURGAM SURESH
Chief Medical Officer
A - Grant
Stock Option (right to buy)
17,916
$0.00
1
$13.67B
2022-03-10
2022-03-14
HALSTEAD MICHAEL
EVP and General Counsel
A - Grant
Restricted Stock Units
22,034
$0.00
1
$13.67B
2022-03-10
2022-03-14
HALSTEAD MICHAEL
EVP and General Counsel
A - Grant
Stock Option (right to buy)
17,916
$0.00
1
$13.67B
2022-03-10
2022-03-14
HINELINE LAWRENCE
SVP of Finance CFO
A - Grant
Restricted Stock Units
16,746
$0.00
1
$13.67B
2022-03-10
2022-03-14
HINELINE LAWRENCE
SVP of Finance CFO
A - Grant
Stock Option (right to buy)
13,616
$0.00
1
$13.67B
2022-03-10
2022-03-14
MATES SHARON
Chairman, President & CEO
A - Grant
Stock Option (right to buy)
50,167
$0.00
1
$13.67B
2022-03-10
2022-03-14
NEUMANN MARK
EVP, Chief Commercial Officer
A - Grant
Restricted Stock Units
22,034
$0.00
1
$13.67B
2022-03-10
2022-03-14
NEUMANN MARK
EVP, Chief Commercial Officer
A - Grant
Stock Option (right to buy)
17,916
$0.00
1
$13.67B
2022-03-09
2022-03-10
MATES SHARON
Chairman, President & CEO
M - Exercise
Stock Option (right to buy)
-38,925
$0.00
1
$13.67B
2022-03-09
2022-03-10
MATES SHARON
Chairman, President & CEO
M - Exercise
Common Stock
38,925
$3.00
117K
1
$13.67B
2022-03-08
2022-03-09
MARCUS JOEL
S - Sale
Common Stock
-15,000
$53.00
-795K
2
$13.67B
2022-03-07
2022-03-09
MARCUS JOEL
S - Sale
Common Stock
-5,000
$55.00
-275K
1
$13.67B
2022-03-04
2022-03-04
DURGAM SURESH
Chief Medical Officer
S - Sale
Common Stock
-3,860
$56.00
-216K
1
$13.67B
2022-03-02
2022-03-04
DURGAM SURESH
Chief Medical Officer
S - Sale
Common Stock
-4,177
$57.00
-238K
1
$13.67B
2022-02-24
2022-02-25
HALSTEAD MICHAEL
EVP and General Counsel
S - Sale
Common Stock
-7,906
$52.00
-411K
2
$13.67B
2022-02-24
2022-02-25
MATES SHARON
Chairman, President & CEO
S - Sale
Common Stock
-22,589
$52.00
-1.17M
3
$13.67B
2022-02-24
2022-02-25
NEUMANN MARK
EVP, Chief Commercial Officer
S - Sale
Common Stock
-7,906
$52.00
-411K
3
$13.67B
2022-02-24
2022-02-25
DURGAM SURESH
Chief Medical Officer
S - Sale
Common Stock
-4,046
$52.00
-210K
3
$13.67B
2022-02-24
2022-02-25
HINELINE LAWRENCE
SVP of Finance CFO
S - Sale
Common Stock
-7,454
$52.00
-388K
3
$13.67B
2022-02-23
2022-02-25
HINELINE LAWRENCE
SVP of Finance CFO
M - Exercise
Restricted Stock Units
-7,454
$0.00
1
$13.67B
2022-02-23
2022-02-25
MATES SHARON
Chairman, President & CEO
M - Exercise
Common Stock
22,589
1
$13.67B
2022-02-23
2022-02-25
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Restricted Stock Units
-7,906
$0.00
1
$13.67B
2022-02-23
2022-02-25
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Common Stock
7,906
1
$13.67B
2022-02-23
2022-02-25
DURGAM SURESH
Chief Medical Officer
M - Exercise
Restricted Stock Units
-7,906
$0.00
1
$13.67B
2022-02-23
2022-02-25
DURGAM SURESH
Chief Medical Officer
M - Exercise
Common Stock
7,906
1
$13.67B
2022-02-23
2022-02-25
HALSTEAD MICHAEL
EVP and General Counsel
M - Exercise
Restricted Stock Units
-7,906
$0.00
1
$13.67B
2022-02-23
2022-02-25
HALSTEAD MICHAEL
EVP and General Counsel
M - Exercise
Common Stock
7,906
1
$13.67B
2022-02-23
2022-02-25
HINELINE LAWRENCE
SVP of Finance CFO
M - Exercise
Common Stock
7,454
1
$13.67B
2022-02-23
2022-02-25
MATES SHARON
Chairman, President & CEO
M - Exercise
Restricted Stock Units
-22,589
$0.00
1
$13.67B
2022-02-22
2022-02-23
MATES SHARON
Chairman, President & CEO
S - Sale
Common Stock
-27,847
$55.00
-1.53M
2
$13.67B
2022-02-22
2022-02-23
NEUMANN MARK
EVP, Chief Commercial Officer
S - Sale
Common Stock
-11,139
$55.00
-613K
2
$13.67B
2022-02-22
2022-02-23
DURGAM SURESH
Chief Medical Officer
S - Sale
Common Stock
-4,177
$55.00
-230K
2
$13.67B
2022-02-22
2022-02-23
HALSTEAD MICHAEL
EVP and General Counsel
S - Sale
Common Stock
-11,139
$55.00
-613K
2
$13.67B
2022-02-22
2022-02-23
HINELINE LAWRENCE
SVP of Finance CFO
S - Sale
Common Stock
-10,443
$55.00
-574K
2
$13.67B
2022-02-18
2022-02-23
HALSTEAD MICHAEL
EVP and General Counsel
M - Exercise
Common Stock
11,139
1
$13.67B
2022-02-18
2022-02-23
HINELINE LAWRENCE
SVP of Finance CFO
M - Exercise
Restricted Stock Units
-10,443
$0.00
1
$13.67B
2022-02-18
2022-02-23
HINELINE LAWRENCE
SVP of Finance CFO
M - Exercise
Common Stock
10,443
1
$13.67B
2022-02-18
2022-02-23
MATES SHARON
Chairman, President & CEO
M - Exercise
Restricted Stock Units
-27,847
$0.00
1
$13.67B
2022-02-18
2022-02-23
MATES SHARON
Chairman, President & CEO
M - Exercise
Common Stock
27,847
1
$13.67B
2022-02-18
2022-02-23
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Restricted Stock Units
-11,139
$0.00
1
$13.67B
2022-02-18
2022-02-23
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Common Stock
11,139
1
$13.67B
2022-02-18
2022-02-23
DURGAM SURESH
Chief Medical Officer
M - Exercise
Restricted Stock Units
-8,354
$0.00
1
$13.67B
2022-02-18
2022-02-23
DURGAM SURESH
Chief Medical Officer
M - Exercise
Common Stock
8,354
1
$13.67B
2022-02-18
2022-02-23
HALSTEAD MICHAEL
EVP and General Counsel
M - Exercise
Restricted Stock Units
-11,139
$0.00
1
$13.67B
2022-01-18
2022-01-20
DURGAM SURESH
Chief Medical Officer
S - Sale
Common Stock
-6,223
$42.00
-261K
1
$13.67B
2022-01-10
2022-01-11
DURGAM SURESH
Chief Medical Officer
S - Sale
Common Stock
-6,870
$41.00
-282K
3
$13.67B
2022-01-10
2022-01-11
HALSTEAD MICHAEL
EVP and General Counsel
S - Sale
Common Stock
-19,639
$41.00
-805K
3
$13.67B
2022-01-10
2022-01-11
HINELINE LAWRENCE
SVP of Finance CFO
S - Sale
Common Stock
-19,639
$41.00
-805K
3
$13.67B
2022-01-10
2022-01-11
MATES SHARON
Chairman, President & CEO
S - Sale
Common Stock
-41,896
$41.00
-1.72M
3
$13.67B
2022-01-10
2022-01-11
NEUMANN MARK
EVP, Chief Commercial Officer
S - Sale
Common Stock
-20,948
$41.00
-859K
3
$13.67B
2022-01-08
2022-01-11
MATES SHARON
Chairman, President & CEO
M - Exercise
Restricted Stock Units
-41,896
$0.00
1
$13.67B
2022-01-08
2022-01-11
HALSTEAD MICHAEL
EVP and General Counsel
M - Exercise
Restricted Stock Units
-19,639
$0.00
1
$13.67B
2022-01-08
2022-01-11
HINELINE LAWRENCE
SVP of Finance CFO
M - Exercise
Common Stock
19,639
1
$13.67B
2022-01-08
2022-01-11
HINELINE LAWRENCE
SVP of Finance CFO
M - Exercise
Restricted Stock Units
-19,639
$0.00
1
$13.67B
2022-01-08
2022-01-11
HALSTEAD MICHAEL
EVP and General Counsel
M - Exercise
Common Stock
19,639
1
$13.67B
2022-01-08
2022-01-11
DURGAM SURESH
Chief Medical Officer
M - Exercise
Restricted Stock Units
-13,093
$0.00
1
$13.67B
2022-01-08
2022-01-11
DURGAM SURESH
Chief Medical Officer
M - Exercise
Common Stock
13,093
1
$13.67B
2022-01-08
2022-01-11
MATES SHARON
Chairman, President & CEO
M - Exercise
Common Stock
41,896
1
$13.67B
2022-01-08
2022-01-11
NEUMANN MARK
EVP, Chief Commercial Officer
M - Exercise
Restricted Stock Units
-20,948
$0.00
1
$13.67B